These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21463665)

  • 1. Mice lacking the peroxisome proliferator-activated receptor α gene present reduced number of dopamine neurons in the substantia nigra without altering motor behavior or dopamine neuron decline over life.
    Gonzalez-Aparicio R; Flores JA; Tasset I; Tunez I; Fernandez-Espejo E
    Neuroscience; 2011 Jul; 186():161-9. PubMed ID: 21463665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The absence of a functional peroxisome proliferator-activated receptor-alpha gene in mice enhances motor sensitizing effects of morphine, but not cocaine.
    Fernandez-Espejo E; Ramiro-Fuentes S; Rodriguez de Fonseca F
    Neuroscience; 2009 Dec; 164(2):667-75. PubMed ID: 19698765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of gamma-synuclein, alpha-synuclein and double alpha/gamma-synuclein null mutant mice.
    Robertson DC; Schmidt O; Ninkina N; Jones PA; Sharkey J; Buchman VL
    J Neurochem; 2004 Jun; 89(5):1126-36. PubMed ID: 15147505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological and functional alterations in the substantia nigra pars compacta of the Mecp2-null mouse.
    Panayotis N; Pratte M; Borges-Correia A; Ghata A; Villard L; Roux JC
    Neurobiol Dis; 2011 Feb; 41(2):385-97. PubMed ID: 20951208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neuregulin receptor, ErbB4, is not required for normal development and adult maintenance of the substantia nigra pars compacta.
    Thuret S; Alavian KN; Gassmann M; Lloyd CK; Smits SM; Smidt MP; Klein R; Dyck RH; Simon HH
    J Neurochem; 2004 Dec; 91(6):1302-11. PubMed ID: 15584907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maturation but not survival of dopaminergic nigrostriatal neurons is affected in developing and aging BDNF-deficient mice.
    Baker SA; Stanford LE; Brown RE; Hagg T
    Brain Res; 2005 Mar; 1039(1-2):177-88. PubMed ID: 15781060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D2 receptor knockout mice develop features of Parkinson disease.
    Tinsley RB; Bye CR; Parish CL; Tziotis-Vais A; George S; Culvenor JG; Li QX; Masters CL; Finkelstein DI; Horne MK
    Ann Neurol; 2009 Oct; 66(4):472-84. PubMed ID: 19847912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosiglitazone decreases peroxisome proliferator receptor-γ levels in microglia and inhibits TNF-α production: new evidences on neuroprotection in a progressive Parkinson's disease model.
    Carta AR; Frau L; Pisanu A; Wardas J; Spiga S; Carboni E
    Neuroscience; 2011 Oct; 194():250-61. PubMed ID: 21839812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A null mutation in TGF-alpha leads to a reduction in midbrain dopaminergic neurons in the substantia nigra.
    Blum M
    Nat Neurosci; 1998 Sep; 1(5):374-7. PubMed ID: 10196526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Running exercise protects the substantia nigra dopaminergic neurons against inflammation-induced degeneration via the activation of BDNF signaling pathway.
    Wu SY; Wang TF; Yu L; Jen CJ; Chuang JI; Wu FS; Wu CW; Kuo YM
    Brain Behav Immun; 2011 Jan; 25(1):135-46. PubMed ID: 20851176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective loss of nigral dopamine neurons induced by overexpression of truncated human alpha-synuclein in mice.
    Wakamatsu M; Ishii A; Iwata S; Sakagami J; Ukai Y; Ono M; Kanbe D; Muramatsu S; Kobayashi K; Iwatsubo T; Yoshimoto M
    Neurobiol Aging; 2008 Apr; 29(4):574-85. PubMed ID: 17174013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalpol attenuates MPTP induced neuronal degeneration of nigral-striatal dopaminergic pathway in mice through elevating glial cell derived neurotrophic factor in striatum.
    Xu G; Xiong Z; Yong Y; Wang Z; Ke Z; Xia Z; Hu Y
    Neuroscience; 2010 Apr; 167(1):174-84. PubMed ID: 20123001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E receptor EP1 enhances GABA-mediated inhibition of dopaminergic neurons in the substantia nigra pars compacta and regulates dopamine level in the dorsal striatum.
    Tanaka Y; Furuyashiki T; Momiyama T; Namba H; Mizoguchi A; Mitsumori T; Kayahara T; Shichi H; Kimura K; Matsuoka T; Nawa H; Narumiya S
    Eur J Neurosci; 2009 Dec; 30(12):2338-46. PubMed ID: 20092576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraquat induces alternation of the dopamine catabolic pathways and glutathione levels in the substantia nigra of mice.
    Kang MJ; Gil SJ; Koh HC
    Toxicol Lett; 2009 Jul; 188(2):148-52. PubMed ID: 19446248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha.
    LoVerme J; Russo R; La Rana G; Fu J; Farthing J; Mattace-Raso G; Meli R; Hohmann A; Calignano A; Piomelli D
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1051-61. PubMed ID: 16997973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective and neurodegenerative effects of the chronic expression of tumor necrosis factor α in the nigrostriatal dopaminergic circuit of adult mice.
    Chertoff M; Di Paolo N; Schoeneberg A; Depino A; Ferrari C; Wurst W; Pfizenmaier K; Eisel U; Pitossi F
    Exp Neurol; 2011 Feb; 227(2):237-51. PubMed ID: 21093436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-18 null mice show diminished microglial activation and reduced dopaminergic neuron loss following acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment.
    Sugama S; Wirz SA; Barr AM; Conti B; Bartfai T; Shibasaki T
    Neuroscience; 2004; 128(2):451-8. PubMed ID: 15350655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine biosynthesis is selectively abolished in substantia nigra/ventral tegmental area but not in hypothalamic neurons in mice with targeted disruption of the Nurr1 gene.
    Castillo SO; Baffi JS; Palkovits M; Goldstein DS; Kopin IJ; Witta J; Magnuson MA; Nikodem VM
    Mol Cell Neurosci; 1998 May; 11(1-2):36-46. PubMed ID: 9608532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system.
    Hunter RL; Dragicevic N; Seifert K; Choi DY; Liu M; Kim HC; Cass WA; Sullivan PG; Bing G
    J Neurochem; 2007 Mar; 100(5):1375-86. PubMed ID: 17254027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Sawada H; Hishida R; Hirata Y; Ono K; Suzuki H; Muramatsu S; Nakano I; Nagatsu T; Sawada M
    J Neurosci Res; 2007 Jun; 85(8):1752-61. PubMed ID: 17469135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.